Weinberg Uri
Chf Medical and Innovation Ofr
Weinberg Uri has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Weinberg Uri is listed as Chf Medical and Innovation Ofr at NovoCure Ltd. Inside the rolling window, Weinberg Uri reported no open-market purchases and 3 open-market sales totaling $232K in NVCR. The largest disclosed transaction in the window is a sale of 7,461 NVCR shares on Feb 27, 2026, worth $103K.
Companies traded
Other insiders at NVCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$232K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Weinberg Uri made?
Weinberg Uri has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Weinberg Uri trade?
Weinberg Uri has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was Weinberg Uri's most recent SEC Form 4 filing?
Weinberg Uri's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Weinberg Uri's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Weinberg Uri is listed as Chf Medical and Innovation Ofr.
What is Weinberg Uri's total buy and sell value in the current window?
Inside the rolling retention window, Weinberg Uri bought $0 and sold $232K based on SEC Form 4 filings.
What was Weinberg Uri's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,461 NVCR shares on 2026-02-27, worth $103K, per SEC Form 4 filings.